Visceral Oncology Center with Colorectal Cancer and Pancreatic Cancer Center
Contact Person:
Kathrin Zierau
Tel.: 0391-6715689
E-Mail:
Disease/Center |
Name of Study |
Short Description |
| Pancreas |
CONKO-007 |
Randomized phase III trial of the value of radiochemotherapy after induction chemotherapy for locally circumscribed unresectable pancreatic cancer: chemotherapy followed by radiochemotherapy compared with chemotherapy alone. |
| Colon |
VALIDATE |
Non-interventional observational study to assess the safety and efficacy of first-line therapy with Vectibix in combination with irinotecan, 5-fluorouracil, and folinic acid (FOLFIRI) and to validate a prognostic score in adult patients with RAS- |